Advanced Biomed Inc. Common Stock (ADVB) vs Enveric Biosciences, Inc. (ENVB)
A side-by-side comparison of Advanced Biomed Inc. Common Stock and Enveric Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADVB
Advanced Biomed Inc. Common Stock
$6.34HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ENVB
Enveric Biosciences, Inc.
$1.51HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ADVB vs ENVB
growth of $100 · dividends reinvested · last 1yADVB -93.1% (-93.1%/yr)ENVB -83.3% (-83.3%/yr)ENVB compounded faster over this window
ADVB ENVB
ADVB vs ENVB: by the numbers
- •ADVB is the larger company ($9M vs $7M market cap).
Metrics side by side
Valuation
| Metric | ADVB | ENVB |
|---|---|---|
| P/B ratio | 0.95 | 0.84 |
Profitability
| Metric | ADVB | ENVB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -7.36% | -108.00% |
| ROIC | -11.06% | -107.99% |
Go deeper
Dig into the metrics
Advanced Biomed Inc. Common Stock ROEEnveric Biosciences ROEAdvanced Biomed Inc. Common Stock operating marginEnveric Biosciences operating marginAdvanced Biomed Inc. Common Stock revenue growthEnveric Biosciences revenue growthAdvanced Biomed Inc. Common Stock free cash flowEnveric Biosciences free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.